GoldenGolden
Advanced Search
ORI Capital

ORI Capital

A Hong Kong based venture capital firm investing in healthcare technology

All edits

Edits on 15 Apr, 2021
Golden AI
Golden AI edited on 15 Apr, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Invested in
Pillar Biosciences
Edits on 28 Mar, 2021
Golden AI
Golden AI edited on 28 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Invested in
Edits on 28 Mar, 2021
Golden AI
Golden AI edited on 28 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Invested in
Edits on 12 Feb, 2020
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 12 Feb, 2020
Edits made to:
Article (+20/-20 characters)
Article

ORI Capital is venture capital firmventure capital firm headquartered in Hong Kong. It was founded in 2015 by Simone Song, who was the Managing Director of China Healthcare at Goldman Sachs from 2010-2015. The management team of the firm is comprised of former Goldman Sachs executives and healthcare scientists. In 2017, the fund was valued at $200 million.

Edits on 28 Jan, 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 28 Jan, 2020
Edits made to:
Article (+9/-9 characters)
Article

ORI Capital is venture capital firm headquartered in Hong KongHong Kong. It was founded in 2015 by Simone Song, who was the Managing Director of China Healthcare at Goldman Sachs from 2010-2015. The management team of the firm is comprised of former Goldman Sachs executives and healthcare scientists. In 2017, the fund was valued at $200 million.

Edits on 3 Nov, 2019
Niroj Manandhar
Niroj Manandhar approved a suggestion from Golden's AI on 3 Nov, 2019
Edits made to:
Article (+13/-13 characters)
Article

ORI Capital is venture capital firm headquartered in Hong Kong. It was founded in 2015 by Simone Song, who was the Managing Director of China Healthcare at Goldman SachsGoldman Sachs from 2010-2015. The management team of the firm is comprised of former Goldman Sachs executives and healthcare scientists. In 2017, the fund was valued at $200 million.

Edits on 30 Oct, 2019
Andrew Craig
Andrew Craig edited on 30 Oct, 2019
Edits made to:
Infobox (+4 properties)
Description (+73 characters)
Article (+538 characters)
Table (+1 rows) (+3 cells) (+88 characters)
Topic thumbnail

ORI Capital

A Hong Kong based venture capital firm investing in healthcare technology

Article

ORI Capital is venture capital firm headquartered in Hong Kong. It was founded in 2015 by Simone Song, who was the Managing Director of China Healthcare at Goldman Sachs from 2010-2015. The management team of the firm is comprised of former Goldman Sachs executives and healthcare scientists. In 2017, the fund was valued at $200 million.

ORI Capital targets investment in the global healthcare technology industry. In 2016, ORI Capital invested $100 million in Kymab, a biopharmeutical company developing human anti-body based therapies.

Table

Name
Role
LinkedIn

Simone Song

Founder

Infobox
Industry
Location
Invested in
Edits on 15 Oct, 2019
Mevludin Mešanović"Approved suggestion #682026"
Mevludin Mešanović approved a suggestion from Golden's AI on 15 Oct, 2019
Edits made to:
Infobox (+1 properties)
Neelam Jhaveri
Neelam Jhaveri edited on 15 Oct, 2019
Edits made to:
Infobox (+1 properties)
Topic thumbnail

ORI Capital

A Hong Kong based venture capital firm investing in healthcare technology

Infobox
Neelam Jhaveri"Initial creation data"
Neelam Jhaveri edited on 15 Oct, 2019
Edits made to:
Infobox (+3 properties)
Infobox
Neelam Jhaveri"Initial topic creation"
Neelam Jhaveri created this topic on 15 Oct, 2019
Edits made to:
Topic thumbnail

 ORI Capital

A Hong Kong based venture capital firm investing in healthcare technology

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.